Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.

Manthei KA, Patra D, Wilson CJ, Fawaz MV, Piersimoni L, Shenkar JC, Yuan W, Andrews PC, Engen JR, Schwendeman A, Ohi MD, Tesmer JJG.

Commun Biol. 2020 Jan 15;3(1):28. doi: 10.1038/s42003-019-0749-z.

PMID:
31942029
2.

Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray drying.

Shi NQ, Zhou J, Walker J, Li L, Hong KY, Olsen KF, Tang J, Ackermann R, Wang Y, Qin B, Schwendeman A, Schwendeman SP.

J Control Release. 2020 Jan 11. pii: S0168-3659(20)30039-0. doi: 10.1016/j.jconrel.2020.01.023. [Epub ahead of print]

PMID:
31935481
3.

Assessment of biosimilarity under native and heat-stressed conditions: rituximab, bevacizumab, and trastuzumab originators and biosimilars.

Kang J, Halseth T, Vallejo D, Najafabadi ZI, Sen KI, Ford M, Ruotolo BT, Schwendeman A.

Anal Bioanal Chem. 2019 Dec 18. doi: 10.1007/s00216-019-02298-9. [Epub ahead of print]

PMID:
31853605
4.

Multifaceted assessment of rituximab biosimilarity: The impact of glycan microheterogeneity on Fc function.

Kang J, Kim SY, Vallejo D, Hageman TS, White DR, Benet A, Coghlan J, Sen KI, Ford M, Saveliev S, Tolbert TJ, Weis DD, Schwendeman SP, Ruotolo BT, Schwendeman A.

Eur J Pharm Biopharm. 2020 Jan;146:111-124. doi: 10.1016/j.ejpb.2019.12.003. Epub 2019 Dec 10.

PMID:
31841688
5.

Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.

Fawaz MV, Kim SY, Li D, Ming R, Xia Z, Olsen K, Pogozheva ID, Tesmer JJG, Schwendeman A.

J Pharmacol Exp Ther. 2020 Feb;372(2):193-204. doi: 10.1124/jpet.119.257568. Epub 2019 Nov 27.

6.

Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseases.

Schultz ML, Fawaz MV, Azaria RD, Hollon TC, Liu EA, Kunkel TJ, Halseth TA, Krus KL, Ming R, Morin EE, McLoughlin HS, Bushart DD, Paulson HL, Shakkottai VG, Orringer DA, Schwendeman AS, Lieberman AP.

BMC Med. 2019 Nov 11;17(1):200. doi: 10.1186/s12916-019-1423-5.

7.

Predicting drug release kinetics from nanocarriers inside dialysis bags.

Yu M, Yuan W, Li D, Schwendeman A, Schwendeman SP.

J Control Release. 2019 Dec 10;315:23-30. doi: 10.1016/j.jconrel.2019.09.016. Epub 2019 Oct 16.

PMID:
31629038
8.

Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.

He H, Liu L, Morin EE, Liu M, Schwendeman A.

Acc Chem Res. 2019 Sep 17;52(9):2445-2461. doi: 10.1021/acs.accounts.9b00228. Epub 2019 Aug 19.

PMID:
31424909
9.

Engineering patient-specific cancer immunotherapies.

Scheetz L, Park KS, Li Q, Lowenstein PR, Castro MG, Schwendeman A, Moon JJ.

Nat Biomed Eng. 2019 Oct;3(10):768-782. doi: 10.1038/s41551-019-0436-x. Epub 2019 Aug 12. Review.

PMID:
31406259
10.

Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.

Wang T, Subramanian C, Yu M, White PT, Kuai R, Sanchez J, Moon JJ, Timmermann BN, Schwendeman A, Cohen MS.

Surgery. 2019 Dec;166(6):1168-1175. doi: 10.1016/j.surg.2019.06.010. Epub 2019 Jul 29.

PMID:
31371177
11.

High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.

Kim SY, Yu M, Morin EE, Kang J, Kaplan MJ, Schwendeman A.

Arthritis Rheumatol. 2020 Jan;72(1):20-30. doi: 10.1002/art.41059. Epub 2019 Nov 26. Review.

PMID:
31350818
12.

Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.

Patel H, Ding B, Ernst K, Shen L, Yuan W, Tang J, Drake LR, Kang J, Li Y, Chen Z, Schwendeman A.

Int J Nanomedicine. 2019 Apr 30;14:3069-3086. doi: 10.2147/IJN.S179837. eCollection 2019.

13.

Inkjet-printed micro-calibration standards for ultraquantitative Raman spectral cytometry.

LaLone V, Fawaz MV, Morales-Mercado J, Mourão MA, Snyder CS, Kim SY, Lieberman AP, Tuteja A, Mehta G, Standiford TJ, Raghavendran K, Shedden K, Schwendeman A, Stringer KA, Rosania GR.

Analyst. 2019 Jun 21;144(12):3790-3799. doi: 10.1039/c9an00500e. Epub 2019 May 22.

PMID:
31116195
14.

High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.

Kadiyala P, Li D, Nuñez FM, Altshuler D, Doherty R, Kuai R, Yu M, Kamran N, Edwards M, Moon JJ, Lowenstein PR, Castro MG, Schwendeman A.

ACS Nano. 2019 Feb 26;13(2):1365-1384. doi: 10.1021/acsnano.8b06842. Epub 2019 Feb 11.

15.

HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic.

Morin EE, Li XA, Schwendeman A.

Front Endocrinol (Lausanne). 2018 Nov 30;9:715. doi: 10.3389/fendo.2018.00715. eCollection 2018. Review.

16.

Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome.

Tang J, Srinivasan S, Yuan W, Ming R, Liu Y, Dai Z, Noble CO, Hayes ME, Zheng N, Jiang W, Szoka FC, Schwendeman A.

Eur J Pharm Biopharm. 2019 Jan;134:107-116. doi: 10.1016/j.ejpb.2018.11.010. Epub 2018 Nov 24.

PMID:
30481559
17.

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Manthei KA, Yang SM, Baljinnyam B, Chang L, Glukhova A, Yuan W, Freeman LA, Maloney DJ, Schwendeman A, Remaley AT, Jadhav A, Tesmer JJ.

Elife. 2018 Nov 27;7. pii: e41604. doi: 10.7554/eLife.41604.

18.

Reverse Engineering the 1-Month Lupron Depot®.

Zhou J, Hirota K, Ackermann R, Walker J, Wang Y, Choi S, Schwendeman A, Schwendeman SP.

AAPS J. 2018 Oct 2;20(6):105. doi: 10.1208/s12248-018-0253-2.

PMID:
30280294
19.

Guest Editorial Title: Nanomedicine: past, present, and future.

Moon JJ, Schwendeman SP, Schwendeman A.

Adv Drug Deliv Rev. 2018 May;130:1-2. doi: 10.1016/j.addr.2018.07.018. No abstract available.

PMID:
30146082
20.

Battle of GLP-1 delivery technologies.

Yu M, Benjamin MM, Srinivasan S, Morin EE, Shishatskaya EI, Schwendeman SP, Schwendeman A.

Adv Drug Deliv Rev. 2018 May;130:113-130. doi: 10.1016/j.addr.2018.07.009. Epub 2018 Jul 21. Review.

21.

NanoDDS 2017: The 15th International Nanomedicine & Drug Delivery Symposium.

Moon JJ, Hennink WE, Schwendeman SP, Schwendeman A.

J Control Release. 2018 Jul 28;282:1-2. doi: 10.1016/j.jconrel.2018.06.009. No abstract available.

PMID:
29914688
22.

Infliximab Biosimilars in the Age of Personalized Medicine.

Kang J, Pisupati K, Benet A, Ruotolo BT, Schwendeman SP, Schwendeman A.

Trends Biotechnol. 2018 Oct;36(10):987-992. doi: 10.1016/j.tibtech.2018.05.002. Epub 2018 May 31. Review.

PMID:
29861288
23.

Synthetic high-density lipoprotein nanoconjugate targets neuroblastoma stem cells, blocking migration and self-renewal.

Subramanian C, White PT, Kuai R, Kalidindi A, Castle VP, Moon JJ, Timmermann BN, Schwendeman A, Cohen MS.

Surgery. 2018 May 9. pii: S0039-6060(18)30080-1. doi: 10.1016/j.surg.2018.01.023. [Epub ahead of print]

24.

Determinants of pH profile and acyl chain selectivity in lysosomal phospholipase A2.

Hinkovska-Galcheva V, Kelly R, Manthei KA, Bouley R, Yuan W, Schwendeman A, Tesmer JJG, Shayman JA.

J Lipid Res. 2018 Jul;59(7):1205-1218. doi: 10.1194/jlr.M084012. Epub 2018 May 3.

25.

Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.

Kuai R, Sun X, Yuan W, Ochyl LJ, Xu Y, Hassani Najafabadi A, Scheetz L, Yu MZ, Balwani I, Schwendeman A, Moon JJ.

J Control Release. 2018 Jul 28;282:131-139. doi: 10.1016/j.jconrel.2018.04.041. Epub 2018 Apr 25.

26.

Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.

Kuai R, Yuan W, Son S, Nam J, Xu Y, Fan Y, Schwendeman A, Moon JJ.

Sci Adv. 2018 Apr 18;4(4):eaao1736. doi: 10.1126/sciadv.aao1736. eCollection 2018 Apr.

27.

Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer.

Nam J, Son S, Ochyl LJ, Kuai R, Schwendeman A, Moon JJ.

Nat Commun. 2018 Mar 14;9(1):1074. doi: 10.1038/s41467-018-03473-9.

28.

Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy.

Kuai R, Sun X, Yuan W, Xu Y, Schwendeman A, Moon JJ.

Bioconjug Chem. 2018 Mar 21;29(3):771-775. doi: 10.1021/acs.bioconjchem.7b00761. Epub 2018 Feb 27.

29.

High-density lipoprotein-mimicking nanodiscs carrying peptide for enhanced therapeutic angiogenesis in diabetic hindlimb ischemia.

Park HJ, Kuai R, Jeon EJ, Seo Y, Jung Y, Moon JJ, Schwendeman A, Cho SW.

Biomaterials. 2018 Apr;161:69-80. doi: 10.1016/j.biomaterials.2018.01.027. Epub 2018 Jan 19.

30.

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.

Guo Y, Yuan W, Yu B, Kuai R, Hu W, Morin EE, Garcia-Barrio MT, Zhang J, Moon JJ, Schwendeman A, Eugene Chen Y.

EBioMedicine. 2018 Feb;28:225-233. doi: 10.1016/j.ebiom.2017.12.021. Epub 2017 Dec 20.

31.

Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.

Li D, Fawaz MV, Morin EE, Ming R, Sviridov D, Tang J, Ackermann R, Olsen K, Remaley AT, Schwendeman A.

Mol Pharm. 2018 Jan 2;15(1):83-96. doi: 10.1021/acs.molpharmaceut.7b00734. Epub 2017 Nov 29.

32.

A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.

Manthei KA, Ahn J, Glukhova A, Yuan W, Larkin C, Manett TD, Chang L, Shayman JA, Axley MJ, Schwendeman A, Tesmer JJG.

J Biol Chem. 2017 Dec 8;292(49):20313-20327. doi: 10.1074/jbc.M117.802736. Epub 2017 Oct 13.

33.

Printing of small molecular medicines from the vapor phase.

Shalev O, Raghavan S, Mazzara JM, Senabulya N, Sinko PD, Fleck E, Rockwell C, Simopoulos N, Jones CM, Schwendeman A, Mehta G, Clarke R, Amidon GE, Shtein M.

Nat Commun. 2017 Sep 27;8(1):711. doi: 10.1038/s41467-017-00763-6.

34.

Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.

Kuai R, Subramanian C, White PT, Timmermann BN, Moon JJ, Cohen MS, Schwendeman A.

Int J Nanomedicine. 2017 Sep 6;12:6581-6594. doi: 10.2147/IJN.S140591. eCollection 2017.

35.

Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.

Pisupati K, Benet A, Tian Y, Okbazghi S, Kang J, Ford M, Saveliev S, Sen KI, Carlson E, Tolbert TJ, Ruotolo BT, Schwendeman SP, Schwendeman A.

MAbs. 2017 Oct;9(7):1197-1209. doi: 10.1080/19420862.2017.1347741. Epub 2017 Aug 8.

36.

Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.

Tang J, Kuai R, Yuan W, Drake L, Moon JJ, Schwendeman A.

Nanomedicine. 2017 Aug;13(6):1869-1878. doi: 10.1016/j.nano.2017.04.009. Epub 2017 Apr 18.

37.

Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Zhang J, Niimi M, Yang D, Liang J, Xu J, Kimura T, Mathew AV, Guo Y, Fan Y, Zhu T, Song J, Ackermann R, Koike Y, Schwendeman A, Lai L, Pennathur S, Garcia-Barrio M, Fan J, Chen YE.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1068-1075. doi: 10.1161/ATVBAHA.117.309114. Epub 2017 Apr 20.

38.

A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima.

Pisupati K, Tian Y, Okbazghi S, Benet A, Ackermann R, Ford M, Saveliev S, Hosfield CM, Urh M, Carlson E, Becker C, Tolbert TJ, Schwendeman SP, Ruotolo BT, Schwendeman A.

Anal Chem. 2017 May 2;89(9):4838-4846. doi: 10.1021/acs.analchem.6b04436. Epub 2017 Apr 17.

39.

Designer vaccine nanodiscs for personalized cancer immunotherapy.

Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ.

Nat Mater. 2017 Apr;16(4):489-496. doi: 10.1038/nmat4822. Epub 2016 Dec 26.

40.

Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.

Yuan Y, Wen J, Tang J, Kan Q, Ackermann R, Olsen K, Schwendeman A.

Int J Nanomedicine. 2016 Nov 22;11:6229-6238. eCollection 2016.

41.

Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization.

Tang J, Li D, Drake L, Yuan W, Deschaine S, Morin EE, Ackermann R, Olsen K, Smith DE, Schwendeman A.

J Lipid Res. 2017 Jan;58(1):124-136. doi: 10.1194/jlr.M071043. Epub 2016 Nov 23.

42.

A High-Throughput Small Molecule Screen for C. elegans Linker Cell Death Inhibitors.

Schwendeman AR, Shaham S.

PLoS One. 2016 Oct 7;11(10):e0164595. doi: 10.1371/journal.pone.0164595. eCollection 2016.

43.

Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.

Doty AC, Hirota K, Olsen KF, Sakamoto N, Ackermann R, Feng MR, Wang Y, Choi S, Qu W, Schwendeman A, Schwendeman SP.

Biomaterials. 2016 Dec;109:88-96. doi: 10.1016/j.biomaterials.2016.07.041. Epub 2016 Aug 18.

PMID:
27693924
44.

Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.

Hirota K, Doty AC, Ackermann R, Zhou J, Olsen KF, Feng MR, Wang Y, Choi S, Qu W, Schwendeman AS, Schwendeman SP.

J Control Release. 2016 Dec 28;244(Pt B):302-313. doi: 10.1016/j.jconrel.2016.08.023. Epub 2016 Aug 24.

PMID:
27565212
45.

Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity.

Smith CK, Seto NL, Vivekanandan-Giri A, Yuan W, Playford MP, Manna Z, Hasni SA, Kuai R, Mehta NN, Schwendeman A, Pennathur S, Kaplan MJ.

Ann Rheum Dis. 2017 Mar;76(3):602-611. doi: 10.1136/annrheumdis-2016-209683. Epub 2016 Aug 19.

46.

Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.

Yuan W, Kuai R, Dai Z, Yuan Y, Zheng N, Jiang W, Noble C, Hayes M, Szoka FC, Schwendeman A.

AAPS J. 2017 Jan;19(1):150-160. doi: 10.1208/s12248-016-9958-2. Epub 2016 Aug 2.

PMID:
27485642
47.

Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal Cells.

Taylor MJ, Sanjanwala AR, Morin EE, Rowland-Fisher E, Anderson K, Schwendeman A, Rainey WE.

Endocrinology. 2016 Aug;157(8):3122-9. doi: 10.1210/en.2014-1663. Epub 2016 Jun 2.

48.

HDL mimetic peptide CER-522 treatment regresses left ventricular diastolic dysfunction in cholesterol-fed rabbits.

Merlet N, Busseuil D, Mihalache-Avram T, Mecteau M, Shi Y, Nachar W, Brand G, Brodeur MR, Charpentier D, Rhainds D, Sy G, Schwendeman A, Lalwani N, Dasseux JL, Rhéaume E, Tardif JC.

Int J Cardiol. 2016 Jul 15;215:364-71. doi: 10.1016/j.ijcard.2016.04.029. Epub 2016 Apr 12.

PMID:
27128563
49.

Reconstitution of the Cytb5-CytP450 Complex in Nanodiscs for Structural Studies using NMR Spectroscopy.

Zhang M, Huang R, Ackermann R, Im SC, Waskell L, Schwendeman A, Ramamoorthy A.

Angew Chem Int Ed Engl. 2016 Mar 24;55(14):4497-9. doi: 10.1002/anie.201600073. Epub 2016 Feb 29.

PMID:
26924779
50.

High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Kuai R, Li D, Chen YE, Moon JJ, Schwendeman A.

ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25. Review.

Supplemental Content

Loading ...
Support Center